Protective effect of Foeniculum vulgare essential oil and anethole in an experimental model of thrombosis M Tognolini, V Ballabeni, S Bertoni, R Bruni, M Impicciatore, E Barocelli Pharmacological research 56 (3), 254-260, 2007 | 269 | 2007 |
Dualsteric GPCR targeting: a novel route to binding and signaling pathway selectivity J Antony, K Kellershohn, M Mohr‐Andrä, A Kebig, S Prilla, M Muth, ... The FASEB Journal 23 (2), 442-450, 2009 | 178 | 2009 |
Elucidating the gut microbiome of ulcerative colitis: bifidobacteria as novel microbial biomarkers S Duranti, F Gaiani, L Mancabelli, C Milani, A Grandi, A Bolchi, A Santoni, ... FEMS microbiology ecology 92 (12), fiw191, 2016 | 162 | 2016 |
Antiplatelet and antithrombotic activities of essential oil from wild Ocotea quixos (Lam.) Kosterm.(Lauraceae) calices from Amazonian Ecuador V Ballabeni, M Tognolini, S Bertoni, R Bruni, A Guerrini, GM Rueda, ... Pharmacological research 55 (1), 23-30, 2007 | 104 | 2007 |
Design, synthesis, and action of oxotremorine-related hybrid-type allosteric modulators of muscarinic acetylcholine receptors T Disingrini, M Muth, C Dallanoce, E Barocelli, S Bertoni, K Kellershohn, ... Journal of medicinal chemistry 49 (1), 366-372, 2006 | 91 | 2006 |
1, 8-Naphthyridines VII. New substituted 5-amino [1, 2, 4] triazolo [4, 3-a][1, 8] naphthyridine-6-carboxamides and their isosteric analogues, exhibiting notable anti … G Roma, G Grossi, M Di Braccio, D Piras, V Ballabeni, M Tognolini, ... European journal of medicinal chemistry 43 (8), 1665-1680, 2008 | 80 | 2008 |
Alterations of intestinal motor responsiveness in a model of mild mesenteric ischemia/reperfusion in rats V Ballabeni, E Barocelli, S Bertoni, M Impicciatore Life sciences 71 (17), 2025-2035, 2002 | 80 | 2002 |
Ocotea quixos Lam. essential oil: In vitro and in vivo investigation on its anti-inflammatory properties V Ballabeni, M Tognolini, C Giorgio, S Bertoni, R Bruni, E Barocelli Fitoterapia 81 (4), 289-295, 2010 | 75 | 2010 |
New polycyclic pyrimidine derivatives with antiplatelet in vitro activity: synthesis and pharmacological screening O Bruno, S Schenone, A Ranise, F Bondavalli, E Barocelli, V Ballabeni, ... Bioorganic & medicinal chemistry 9 (3), 629-636, 2001 | 74 | 2001 |
The selective inhibition of inducible nitric oxide synthase prevents intestinal ischemia–reperfusion injury in mice E Barocelli, V Ballabeni, P Ghizzardi, F Cattaruzza, S Bertoni, ... Nitric Oxide 14 (3), 212-218, 2006 | 67 | 2006 |
Synthesis, biological activity, QSAR and QSPR study of 2-aminobenzimidazole derivatives as potent H3-antagonists M Mor, F Bordi, C Silva, S Rivara, V Zuliani, F Vacondio, M Rivara, ... Bioorganic & medicinal chemistry 12 (4), 663-674, 2004 | 66 | 2004 |
Indole‐based analogs of melatonin: in vitro antioxidant and cytoprotective activities M Mor, C Silva, F Vacondio, PV Plazzi, S Bertoni, G Spadoni, ... Journal of pineal research 36 (2), 95-102, 2004 | 63 | 2004 |
1, 8-Naphthyridines VIII. Novel 5-aminoimidazo [1, 2-a][1, 8] naphthyridine-6-carboxamide and 5-amino [1, 2, 4] triazolo [4, 3-a][1, 8] naphthyridine-6-carboxamide derivatives … G Roma, M Di Braccio, G Grossi, D Piras, V Ballabeni, M Tognolini, ... European journal of medicinal chemistry 45 (1), 352-366, 2010 | 58 | 2010 |
Synthesis and functional characterization of novel derivatives related to oxotremorine and oxotremorine-M C Dallanoce, P Conti, M De Amici, C De Micheli, E Barocelli, M Chiavarini, ... Bioorganic & medicinal chemistry 7 (8), 1539-1547, 1999 | 58 | 1999 |
Validation of a histamine H3 receptor model through structure–activity relationships for classical H3 antagonists S Lorenzi, M Mor, F Bordi, S Rivara, M Rivara, G Morini, S Bertoni, ... Bioorganic & medicinal chemistry 13 (19), 5647-5657, 2005 | 54 | 2005 |
Effect of N-methyl-d-aspartate receptor blockade on neuronal plasticity and gastrointestinal transit delay induced by ischemia/reperfusion in rats F Calcina, E Barocelli, S Bertoni, O Furukawa, J Kaunitz, M Impicciatore, ... Neuroscience 134 (1), 39-49, 2005 | 53 | 2005 |
Synthesis and structure–activity relationships for biphenyl H3 receptor antagonists with moderate anti-cholinesterase activity G Morini, M Comini, M Rivara, S Rivara, F Bordi, PV Plazzi, L Flammini, ... Bioorganic & medicinal chemistry 16 (23), 9911-9924, 2008 | 46 | 2008 |
Δ5-Cholenoyl-amino acids as selective and orally available antagonists of the Eph–ephrin system R Castelli, M Tognolini, F Vacondio, M Incerti, D Pala, D Callegari, ... European journal of medicinal chemistry 103, 312-324, 2015 | 43 | 2015 |
Synthesis and Biological Evaluation of N-Pyrazolyl-N‘-alkyl/benzyl/phenylureas: a New Class of Potent Inhibitors of Interleukin 8-Induced Neutrophil Chemotaxis O Bruno, C Brullo, F Bondavalli, S Schenone, A Ranise, N Arduino, ... Journal of medicinal chemistry 50 (15), 3618-3626, 2007 | 41 | 2007 |
Bis (ammonio) alkane-type agonists of muscarinic acetylcholine receptors: Synthesis, in vitro functional characterization, and in vivo evaluation of their analgesic activity C Matera, L Flammini, M Quadri, V Vivo, V Ballabeni, U Holzgrabe, ... European journal of medicinal chemistry 75, 222-232, 2014 | 39 | 2014 |